MRTX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-06 | 2021 | James Christensen, Ph.D. Chief Scientific Officer | 515,000 | 0 | 0 | 254,925 | 14,500 | 11,548,796 |
| 2023-04-06 | 2021 | Vickie Reed Former Chief Accounting Officer | 386,250 | 0 | 0 | 169,950 | 14,500 | 4,224,496 |
| 2023-04-06 | 2022 | Vickie Reed Former Chief Accounting Officer | 230,133 | 0 | 0 | 0 | 471,410 | 2,038,354 |
| 2023-04-06 | 2022 | Laurie Stelzer | 315,962 | 0 | 0 | 143,100 | 150,000 | 5,796,064 |
| 2023-04-06 | 2022 | James Christensen, Ph.D. Chief Scientific Officer | 532,308 | 0 | 0 | 1,215,865 | 15,250 | 5,008,064 |
| 2023-04-06 | 2020 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 615,013 | 0 | 0 | 498,161 | 14,250 | 11,747,582 |
| 2023-04-06 | 2021 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 662,200 | 0 | 0 | 437,052 | 14,500 | 18,358,022 |
| 2023-04-06 | 2022 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 684,508 | 0 | 0 | 370,120 | 15,250 | 7,420,213 |
| 2023-04-06 | 2021 | David Meek Chief Executive Officer | 181,250 | 0 | 0 | 172,792 | 76,737 | 20,178,130 |
| 2023-04-06 | 2022 | David Meek Chief Executive Officer | 749,423 | 0 | 0 | 438,985 | 471,651 | 11,937,371 |
| 2023-04-06 | 2022 | Alan Sandler, M.D. | 88,646 | 0 | 0 | 0 | 0 | 4,793,850 |
| 2023-04-06 | 2020 | James Christensen, Ph.D. Chief Scientific Officer | 500,000 | 0 | 0 | 303,750 | 16,301 | 6,988,546 |
| 2022-04-15 | 2021 | Daniel Faga Former Executive Vice President and Chief Operating Officer | 427,848 | 0 | 0 | 0 | 1,070,814 | 7,716,255 |
| 2022-04-15 | 2021 | David Meek | 181,250 | 0 | 0 | 172,792 | 76,737 | 20,178,130 |
| 2022-04-15 | 2021 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 662,200 | 0 | 0 | 437,052 | 14,500 | 18,358,022 |
| 2022-04-15 | 2020 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 615,013 | 0 | 0 | 498,161 | 14,250 | 11,747,582 |
| 2022-04-15 | 2019 | Charles M. Baum, M.D., Ph.D. President, Founder, Head of R&D | 597,100 | 0 | 0 | 410,506 | 2,500 | 8,484,393 |
| 2022-04-15 | 2021 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 515,000 | 0 | 0 | 254,925 | 14,500 | 11,548,796 |
| 2022-04-15 | 2020 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 500,000 | 0 | 0 | 303,750 | 16,301 | 6,988,546 |
| 2022-04-15 | 2019 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 435,000 | 0 | 0 | 217,500 | 2,500 | 3,292,984 |
| 2022-04-15 | 2021 | Benjamin Hickey Executive Vice President and Chief Commercial Officer | 504,700 | 0 | 0 | 249,826 | 14,500 | 6,927,560 |
| 2022-04-15 | 2020 | Benjamin Hickey Executive Vice President and Chief Commercial Officer | 484,346 | 0 | 0 | 297,675 | 16,296 | 5,798,359 |
| 2022-04-15 | 2021 | Vickie Reed | 386,250 | 0 | 0 | 169,950 | 14,500 | 4,224,496 |
| 2022-04-15 | 2020 | Daniel Faga Former Executive Vice President and Chief Operating Officer | 494,231 | 0 | 0 | 303,750 | 362,373 | 9,459,162 |
| 2021-04-16 | 2018 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 579,700 | 0 | 0 | 434,800 | 2,500 | 4,868,079 |
| 2021-04-16 | 2020 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 500,000 | 0 | 0 | 303,750 | 16,301 | 6,988,546 |
| 2021-04-16 | 2019 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 435,000 | 0 | 0 | 217,500 | 2,500 | 3,292,984 |
| 2021-04-16 | 2018 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 374,385 | 0 | 0 | 247,200 | 2,500 | 3,195,460 |
| 2021-04-16 | 2020 | Daniel Faga | 494,231 | 0 | 0 | 303,750 | 362,373 | 9,160,360 |
| 2021-04-16 | 2020 | Benjamin Hickey | 484,346 | 0 | 0 | 297,675 | 16,296 | 5,798,359 |
| 2021-04-16 | 2020 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 1,439 | 0 | 0 | 0 | 422,122 | 423,561 |
| 2021-04-16 | 2019 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 373,900 | 0 | 0 | 186,950 | 2,500 | 3,201,334 |
| 2021-04-16 | 2018 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 363,000 | 0 | 0 | 217,800 | 2,500 | 1,624,132 |
| 2021-04-16 | 2020 | Isan Chen, M.D. Former Executive Vice President and Chief Medical Officer | 198,676 | 0 | 0 | 0 | 485,281 | 683,957 |
| 2021-04-16 | 2019 | Isan Chen, M.D. Former Executive Vice President and Chief Medical Officer | 433,100 | 0 | 0 | 216,550 | 2,500 | 3,290,134 |
| 2021-04-16 | 2018 | Isan Chen, M.D. Former Executive Vice President and Chief Medical Officer | 420,500 | 0 | 0 | 252,300 | 2,500 | 1,716,132 |
| 2021-04-16 | 2020 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 615,013 | 0 | 0 | 498,161 | 14,250 | 11,747,582 |
| 2021-04-16 | 2019 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 597,100 | 0 | 0 | 410,506 | 2,500 | 8,484,393 |
| 2020-04-17 | 2019 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 597,100 | 0 | 0 | 410,506 | 2,500 | 8,484,393 |
| 2020-04-17 | 2018 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 579,700 | 0 | 0 | 434,800 | 2,500 | 4,868,079 |
| 2020-04-17 | 2017 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 562,800 | 0 | 0 | 225,100 | 2,500 | 1,622,101 |
| 2020-04-17 | 2019 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 433,100 | 0 | 0 | 216,550 | 2,500 | 3,290,134 |
| 2020-04-17 | 2018 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 420,500 | 0 | 0 | 252,300 | 2,500 | 1,716,132 |
| 2020-04-17 | 2017 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 408,300 | 0 | 0 | 130,700 | 2,500 | 753,400 |
| 2020-04-17 | 2019 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 435,000 | 0 | 0 | 217,500 | 2,500 | 3,292,984 |
| 2020-04-17 | 2018 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 374,385 | 0 | 0 | 247,200 | 2,500 | 3,195,460 |
| 2020-04-17 | 2017 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 360,700 | 0 | 0 | 115,400 | 2,500 | 690,500 |
| 2020-04-17 | 2019 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 373,900 | 0 | 0 | 186,950 | 2,500 | 3,201,334 |
| 2020-04-17 | 2018 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 363,000 | 0 | 0 | 217,800 | 2,500 | 1,624,132 |
| 2020-04-17 | 2017 | Jamie A. Donadio Former Senior Vice President and Chief Financial Officer | 330,000 | 0 | 0 | 105,600 | 2,500 | 650,000 |
| 2020-04-17 | 2019 | Chris LeMasters Former Executive Vice President and Chief Business Officer | 373,900 | 0 | 0 | 186,950 | 2,500 | 3,201,334 |
| 2020-04-17 | 2018 | Chris LeMasters Former Executive Vice President and Chief Business Officer | 363,000 | 0 | 0 | 217,800 | 2,500 | 1,936,382 |
| 2020-04-17 | 2017 | Chris LeMasters Former Executive Vice President and Chief Business Officer | 342,550 | 0 | 0 | 109,600 | 2,500 | 502,327 |
| 2019-04-19 | 2018 | Jamie A. Donadio Senior Vice President and Chief Financial Officer | 363,000 | 0 | 0 | 217,800 | 2,500 | 1,624,132 |
| 2019-04-19 | 2018 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 579,700 | 0 | 0 | 434,800 | 2,500 | 4,868,079 |
| 2019-04-19 | 2017 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 562,800 | 0 | 0 | 225,100 | 2,500 | 1,622,101 |
| 2019-04-19 | 2018 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 420,500 | 0 | 0 | 252,300 | 2,500 | 1,716,132 |
| 2019-04-19 | 2017 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 408,300 | 0 | 0 | 130,700 | 2,500 | 753,400 |
| 2019-04-19 | 2018 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 374,385 | 0 | 0 | 247,200 | 2,500 | 3,195,460 |
| 2019-04-19 | 2017 | James Christensen, Ph.D. Executive Vice President and Chief Scientific Officer | 360,700 | 0 | 0 | 115,400 | 2,500 | 690,500 |
| 2019-04-19 | 2017 | Jamie A. Donadio Senior Vice President and Chief Financial Officer | 330,000 | 0 | 0 | 105,600 | 2,500 | 650,000 |
| 2019-04-19 | 2018 | Chris LeMasters Executive Vice President and Chief Business Officer | 363,000 | 0 | 0 | 217,800 | 2,500 | 1,936,382 |
| 2019-04-19 | 2017 | Chris LeMasters Executive Vice President and Chief Business Officer | 342,550 | 0 | 0 | 109,600 | 2,500 | 502,327 |
| 2018-04-20 | 2017 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 360,700 | 0 | 0 | 115,400 | 2,920 | 690,920 |
| 2018-04-20 | 2016 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 396,224 | 0 | 0 | 95,136 | 2,831 | 1,673,580 |
| 2018-04-20 | 2017 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 562,800 | 0 | 0 | 225,100 | 2,920 | 1,622,521 |
| 2018-04-20 | 2016 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 546,155 | 0 | 0 | 163,920 | 2,831 | 2,973,400 |
| 2018-04-20 | 2017 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 408,300 | 0 | 0 | 130,700 | 2,920 | 753,820 |
| 2018-04-20 | 2016 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 350,051 | 0 | 0 | 84,048 | 2,831 | 1,747,278 |
| 2017-04-20 | 2015 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 384,779 | 0 | 0 | 130,900 | 2,814 | 1,044,093 |
| 2017-04-20 | 2015 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 339,678 | 0 | 0 | 115,600 | 2,814 | 983,692 |
| 2017-04-20 | 2016 | Mark J. Gergen Former Executive Vice President and Chief Operations Officer | 283,909 | 0 | 0 | 0 | 512,747 | 1,976,045 |
| 2017-04-20 | 2015 | Mark J. Gergen Former Executive Vice President and Chief Operations Officer | 396,286 | 0 | 0 | 134,800 | 2,814 | 1,059,500 |
| 2017-04-20 | 2016 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 546,155 | 0 | 0 | 163,920 | 2,831 | 2,973,400 |
| 2017-04-20 | 2015 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 530,272 | 0 | 0 | 225,500 | 2,814 | 2,247,786 |
| 2017-04-20 | 2016 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 411,032 | 0 | 0 | 95,136 | 2,831 | 1,688,388 |
| 2017-04-20 | 2016 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 350,051 | 0 | 0 | 84,048 | 2,831 | 1,747,278 |
| 2016-04-19 | 2015 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 396,286 | 0 | 0 | 134,800 | 2,814 | 1,059,500 |
| 2016-04-19 | 2014 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016-04-19 | 2015 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 384,779 | 0 | 0 | 130,900 | 2,814 | 1,044,093 |
| 2016-04-19 | 2014 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 399,180 | 0 | 0 | 92,360 | 2,975 | 1,257,343 |
| 2016-04-19 | 2015 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 530,272 | 0 | 0 | 225,500 | 2,814 | 2,247,786 |
| 2016-04-19 | 2014 | Charles M. Baum, M.D., Ph.D. President and Chief Executive Officer | 534,116 | 0 | 0 | 154,500 | 78 | 2,977,100 |
| 2015-04-23 | 2014 | Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer | 534,116 | 0 | 0 | 154,500 | 78 | 2,977,178 |
| 2015-04-23 | 2013 | Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer | 500,000 | 0 | 0 | 280,000 | 5,194 | 2,323,707 |
| 2015-04-23 | 2014 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 399,180 | 0 | 0 | 92,360 | 2,975 | 1,257,343 |
| 2015-04-23 | 2013 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 311,539 | 0 | 0 | 155,000 | 3,120 | 1,449,604 |
| 2015-04-23 | 2014 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 319,154 | 0 | 0 | 55,800 | 2,975 | 1,293,323 |
| 2015-04-23 | 2013 | James Christensen, Ph.D. Senior Vice President and Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2014-04-17 | 2012 | Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer | 135,438 | 0 | 0 | 0 | 0 | 1,445,262 |
| 2014-04-17 | 2012 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2014-04-17 | 2013 | Isan Chen, M.D. Executive Vice President and Chief Medical and Development Officer | 106,731 | 0 | 0 | 45,000 | 2,819 | 1,847,722 |
| 2014-04-17 | 2012 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2014-04-17 | 2013 | Mark J. Gergen Executive Vice President and Chief Operations Officer | 311,539 | 0 | 0 | 155,000 | 3,120 | 1,449,603 |
| 2014-04-17 | 2013 | Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer | 500,000 | 0 | 0 | 280,000 | 5,194 | 2,323,707 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
